Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
venerdì, ottobre 09
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Zimmer Biomet Holdings Inc
ZBH
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$88.88
0.39
0.44%
Ult. Agg.: Oct 8, 4:03 PM
$88.88
0.39
0.44%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Zimmer Biomet Holdings Financials
Zimmer Biomet Holdings (ZBH) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Zimmer Biomet Reiterates Its FY 2026 Financial Outlook
Zimmer Biomet also announced today that the Company is reiterating its full-year 2026 financial outlook provided on August 5, 2026.
Benzinga Newsdesk
PRO
Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437B-$8.602B to $8.553B-$8.635B vs $8.544B Est
Zimmer Biomet Holdings (NYSE:ZBH) raises FY2026 Adj EPS guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 analyst estimate. Raises FY2026 sales outlook from $8.437 billion-$8.602 billion to $8.553 billion-$8.635 billion
Benzinga Newsdesk
PRO
Zimmer Biomet Holdings Q2 Adj. EPS $2.07 Beats $2.01 Estimate, Sales $2.177B Beat $2.134B Estimate
Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $2.07 per share which beat the analyst consensus estimate of $2.01 by 2.99 percent. This is unchanged from the same period last year. The company
Benzinga Newsdesk
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...'
Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that disappoint Wall Street.
Tanya Rawat
These Analysts Slash Their Forecasts On Zimmer Biomet Following Q1 Results
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported strong Q1 earnings, beating estimates and raising guidance. Analysts maintain mixed views on stock.
Avi Kapoor
Tariffs Benefit, CFO Exit: What's Going On With Zimmer Biomet Stock On Tuesday?
Zimmer Biomet raises guidance, flags tariff benefit, names interim CFO, and outlines timeline for AI-driven robotic system rollout.
Vandana Singh
